Vaccination Recommendations for Adults Receiving Biologics and Oral Therapies for Psoriasis and Psoriatic Arthritis: Delphi Consensus from the Medical Board of the National Psoriasis Foundation
abatacept, acitretin, adalimumab, apremilast, biologics, brodalumab, certolizumab, cyclosporine, deucravacitinib, etanercept, golimumab, guselkumab, infliximab, ixekizumab, methotrexate, psoriasis, psoriatic arthritis, recommendation, risankizumab, secukinumab, tildrakizumab, tofacitinib, ustekinumab, vaccination, vaccines,
Related Posts
Qin M, Evron E, Tran PT, Deng M, Nelson AM, Kim J, Agak GW. Immune activation and glycolytic responses to Cutibacterium acnes cell wall polysaccharides.[...]
Kapse B, Mohanty RP, Wax M, Gao Y, Tran L, Wolters PJ, Pellegrini M, Singer JP, Greenland JR. Frailty in lung transplant recipients is associated[...]
Yan MJ, Phan H, Hsu S, Kang Y, Yu Y. Toxic Epidermal Necrolysis-Like Acute Cutaneous Lupus Erythematosus Following an Upper Respiratory Infection. Cureus. 2025 Apr[...]